Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
		
    Deep learning derived tumor infiltration maps for personalized target definition in Glioblastoma radiotherapy.
        
        Radiother. Oncol. 138, 166-172 (2019)
    
    
    
				Purpose: Glioblastoma is routinely treated by concomitant radiochemotherapy. Current target definition guidelines use anatomic MRI (magnetic resonance imaging) scans, taking into account contrast enhancement and the rather unspecific hyperintensity on the fluid-attenuated inversion recovery (FLAIR) sequence.Methods and materials: We applied deep learning based free water correction of diffusion tensor imaging (DTI) scans to estimate the infiltrative gross tumor volume (iGTV) inside of the FLAIR hyperintense region. We analyzed the resulting iGTVs and their impact on target volume definition in a retrospective cohort of 33 GBM patients.Results: iGTVs were significantly smaller compared to standard pre-and post-operative gross tumor volume (GTV) definitions. Two novel infiltrative tumor GTVs (nGTV(PRE-OP) and nGTV(POST-OP)) defined as the conjunction volume of the standard GTV and the iGTV showed only a moderate increase in size compared to standard GTV definitions. On postoperative scans, the iGTV was predominantly covered by the two clinical target volume (CTV) concepts CTVEORTC and CTVROTG1. A novel infiltrative tumor CTV (nCTV) [nGTV(POST-OP) + 2 cm margin] was significantly smaller compared to CTVROTG1 but larger than CTVEORTC. The overlap volume and conformity index demonstrated a distinct spatial configuration of the nCTV. Tumor recurrences overlapped with the iGTV in all but one patients and were completely covered by the nCTV in all patients. After reducing the margin to 1 cm recurrences coverage was at least in-field in all patients.Conclusion: To conclude, free water corrected DTI scans may help to define infiltrative tumor areas of GBM that could ultimately be used to individualize RT treatment planning in terms of dose sparing or dose escalation.
			
			
		Impact Factor
					Scopus SNIP
					Web of Science
Times Cited
					Times Cited
Scopus
Cited By
					
					Cited By
Altmetric
					
				5.252
					1.562
					14
					19
					
					
				Anmerkungen
				
					
						 
						
					
				
			
				
			
				Besondere Publikation
				
					
						 
					
				
			
			
			
				Auf Hompepage verbergern
				
					
						 
					
				
			
			
        Publikationstyp
        Artikel: Journalartikel
    
 
    
        Dokumenttyp
        Wissenschaftlicher Artikel
    
 
     
    
    
        Schlagwörter
        Glioblastoma ; Deep Learning ; Radiotherapy ; Personalized Medicine ; Diffusion Tensor Imaging ; Tissue Volume Maps; Newly-diagnosed Glioblastoma; Free-water Elimination; Randomized Phase-iii; High-grade Gliomas; Adjuvant Temozolomide; Radiation-therapy; Fet-pet; Multiforme; Patterns; Failure
    
 
     
    
    
        Sprache
        
    
 
    
        Veröffentlichungsjahr
        2019
    
 
     
    
        HGF-Berichtsjahr
        2019
    
 
    
    
        ISSN (print) / ISBN
        0167-8140
    
 
    
        e-ISSN
        1879-0887
    
 
     
     
     
	     
	 
	 
    
        Zeitschrift
        Radiotherapy and Oncology
    
 
		
    
        Quellenangaben
        
	    Band: 138,  
	    
	    Seiten: 166-172 
	    
	    
	
    
 
  
         
        
            Verlag
            Elsevier
        
 
        
            Verlagsort
            Elsevier House, Brookvale Plaza, East Park Shannon, Co, Clare, 00000, Ireland
        
 
	
         
         
         
         
         
	
         
         
         
    
         
         
         
         
         
         
         
    
        Begutachtungsstatus
        Peer reviewed
    
 
    
        Institut(e)
        Institute of Radiation Medicine (IRM)
    
 
    
        POF Topic(s)
        30203 - Molecular Targets and Therapies
    
 
    
        Forschungsfeld(er)
        Radiation Sciences
    
 
    
        PSP-Element(e)
        G-501300-001
    
 
     
     	
    
    
        WOS ID
        WOS:000482210600024
    
    
        PubMed ID
        31302391
    
    
        Erfassungsdatum
        2019-08-01